Vit D3 and Omega 3 in Chemo Induced Neuropathy

• Status: Unknown status
• Trial end date: 2016-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether administration of mammalian Omega 3 FA(fatty acid) with Vitamin D3 supplements would lower or prevent the risk of neuropathy due to chemotherapy.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: McGill University Health Center; McGill University Health Centre/Research Institute of the McGill University Health Centre
• Treatments: Cholecalciferol; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• Will be receiving chemotherapy(Platinums and/or Taxanes) in the following 2 weeks.

• Histologically confirmed diagnosis of cancer

• ECOG 0 to 2

Exclusion Criteria:

• Prior chemotherapy treatment

• Pre-existing peripheral PN due to DM,HIV, alcohol abuse, thyroid dysfunction and hereditary PN associated disorders.

• Taking any nutritional supplement( fish oil, vitamins and minerals) at least there months before enrollment.